BUSINESSMARKETWATCH
Walmart shares slide as U.S. sales hit by falling drug prices
Walmart shares slid because U.S. sales were impacted by falling drug prices. The supermarket chain reported comparable U.S. sales growth of 2.6% in its second-quarter earnings, which was the lowest rate in over six years.
Related Signal
Adjacent reporting
- Walmart sees the slowest pace in US comparable sales in 6 years and offers cautious guidance
- Walmart strong again in second quarter, but its outlook is reserved
- Walmart stock plunges as soaring gas prices hit profits and slam shoppers’ wallets
- Walmart strong again in second quarter, but its outlook is reserved
- Walmart’s stock was once a market darling. Now its tech-fueled valuation faces a reality check.
- Walmart sees slowing sales growth and warns of a profit miss, in contrast to rival Target